Total Payments
$10,688
2024 Payments
$2,724
Companies
29
Transactions
705
Medicare Patients
1,559
Medicare Billing
$92,582
Payment Breakdown by Category
Food & Beverage$10,651 (99.6%)
Education$37.43 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,651 | 702 | 99.6% |
| Education | $37.43 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,134 | 186 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,290 | 191 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $763.24 | 43 | $0 (2024) |
| PFIZER INC. | $706.02 | 49 | $0 (2024) |
| Celgene Corporation | $584.01 | 38 | $0 (2024) |
| Janssen Biotech, Inc. | $569.95 | 41 | $0 (2024) |
| Daiichi Sankyo Inc. | $478.58 | 29 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $288.71 | 10 | $0 (2024) |
| GENZYME CORPORATION | $278.42 | 11 | $0 (2024) |
| Gilead Sciences, Inc. | $245.07 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,724 | 166 | ABBVIE INC. ($769.04) |
| 2023 | $2,048 | 129 | ABBVIE INC. ($540.62) |
| 2022 | $2,927 | 188 | ABBVIE INC. ($992.82) |
| 2021 | $2,989 | 222 | AbbVie Inc. ($831.06) |
All Payment Transactions
705 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/02/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/20/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/20/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.46 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.86 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 389 | 403 | $82,745 | $24,774 |
| 2022 | 5 | 385 | 406 | $79,960 | $23,381 |
| 2021 | 6 | 420 | 438 | $80,165 | $25,119 |
| 2020 | 6 | 365 | 383 | $71,905 | $19,307 |
Total Patients
1,559
Total Services
1,630
Medicare Billing
$92,582
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 175 | 186 | $29,760 | $9,405 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 73 | $17,155 | $5,585 | 32.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 83 | 83 | $19,505 | $5,202 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $14,235 | $3,794 | 26.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 22 | $2,090 | $788.97 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 170 | 188 | $30,080 | $9,465 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 73 | $17,155 | $5,309 | 30.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 91 | 91 | $21,385 | $5,190 | 24.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $8,395 | $2,327 | 27.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 31 | 31 | $2,945 | $1,090 | 37.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 160 | 173 | $27,680 | $9,741 | 35.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 73 | $17,155 | $5,387 | 31.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 77 | 77 | $18,095 | $4,917 | 27.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 79 | 82 | $7,790 | $2,362 | 30.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $7,300 | $2,099 | 28.8% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 13 | 13 | $2,145 | $611.79 | 28.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 166 | 182 | $29,120 | $8,215 | 28.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 68 | 68 | $15,980 | $4,130 | 25.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 32 | 32 | $11,680 | $2,605 | 22.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 33 | 34 | $7,990 | $2,349 | 29.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 55 | 56 | $5,320 | $1,496 | 28.1% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 11 | 11 | $1,815 | $511.57 | 28.2% |
About Kara Herrera, P.A
Kara Herrera, P.A is a Physician Assistant healthcare provider based in Round Rock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821074543.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kara Herrera, P.A has received a total of $10,688 in payments from pharmaceutical and medical device companies, with $2,724 received in 2024. These payments were reported across 705 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($10,651).
As a Medicare-enrolled provider, Herrera has provided services to 1,559 Medicare beneficiaries, totaling 1,630 services with total Medicare billing of $92,582. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Medical
- Location Round Rock, TX
- Active Since 12/15/2005
- Last Updated 02/26/2024
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1821074543
Products in Payments
- XIFAXAN (Drug) $1,848
- MAVYRET (Drug) $1,117
- RINVOQ (Biological) $733.64
- XELJANZ (Drug) $645.80
- ENTYVIO (Biological) $628.00
- ZEPOSIA (Drug) $608.65
- DUPIXENT (Biological) $567.13
- INJECTAFER (Drug) $478.58
- HUMIRA (Biological) $446.87
- TRULANCE (Drug) $418.82
- SKYRIZI (Biological) $358.82
- STELARA (Biological) $331.86
- ZENPEP (Drug) $301.72
- LINZESS (Drug) $209.66
- CREON (Drug) $160.04
- TREMFYA (Drug) $150.74
- Talicia (Drug) $123.92
- Linzess (Drug) $115.87
- VIBERZI (Drug) $107.27
- GATTEX (Drug) $87.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Round Rock
Mr. Dustin Fontenot, P.a, P.A
Physician Assistant — Payments: $38,415
Physician Assistant $38,415
Stephanie Doggett, Pa-C, PA-C
Physician Assistant — Payments: $23,275
Physician Assistant $23,275
Eden Warrick, Pa-C, PA-C
Physician Assistant — Payments: $16,062
Physician Assistant $16,062
Caitlin Keen, Pa-C, PA-C
Physician Assistant — Payments: $9,265
Physician Assistant $9,265
Emily Davis, Pa-C, PA-C
Physician Assistant — Payments: $9,041
Physician Assistant $9,041
Katherine Roehm, Pa-C, PA-C
Physician Assistant — Payments: $8,228
Physician Assistant $8,228